Webcast Alert: Biophan Technologies, Isonics Corp., MFIC and Molecular Imaging to Present at Trilogy Capital's Online Nanotechnology Forum on Friday, May 7, 2004

[Trilogy Capital Partners via BizWire]

LOS ANGELES--(BUSINESS WIRE)--April 29, 2004--

Online Conference to Focus on Scientific Breakthroughs in
Burgeoning Nanotech Industry

Trilogy Capital Partners, Inc. announced today that it is
sponsoring an online Nanotechnology conference on Friday May 7th at 12
pm Eastern. The conference, Trilogy Capital's Online Nanotechnology
Forum, will feature five emerging growth Microcap public companies
excelling in nanotechnology and related markets. The current schedule
of presenting companies is: Biophan Technologies, Inc. (OTC BB: BIPH),
Isonics Corporation (NASDAQ: ISON), MFIC Corporation (OTC BB: MFIC)
and Molecular Imaging Corporation (OTC BB: MLRI).
"The companies which occupy the nanotech universe represent the
cutting edge of the future of science as nanotechnology moves from the
laboratory into the mainstream," stated A.J. Cervantes, president of
Trilogy and forum moderator. "For those investors who are interested
in nanotechnology, this forum represents the opportunity to meet the
senior management of five potentially high-growth companies in a
convenient, fast-paced 30 minute presentation. We encourage investors
and other interested parties to visit www.trilogy-capital.com to learn
more about these excellent companies."

What: Biophan Technologies, Isonics Corporation, MFIC
Corporation and Molecular Imaging to Present at Trilogy
Capital Partners' inaugural Online Nanotechnology Forum.
More companies are expected to be announced in the coming
days.

Who: Conference Moderator: A.J. Cervantes, President - Trilogy
Capital Partners, Inc. Keynote speaker to be announced.

When: Friday, May 7, 2004 12:00PM Eastern

Where: Please register at www.trilogy-capital.com.
Pre-registration is required.

Cost: The conference is completely free of charge.

How: Live over the Internet - registered attendees will
receive instructions via email prior to the event.

Archive: If you are unable to participate during the live
webcast, the Forum will be archived for replay at
www.trilogy-capital.com.

Biophan Technologies, Inc. (OTC BB: BIPH) Committed to growth
through innovation and developmental leadership, Biophan and its
licensors have nine issued U.S. patents and over fifty patents
pending, in areas including nanotechnology (nanomagnetic particle
coatings), radio frequency filters, polymer composites, and photonics.
Biophan's technology will help realize its goal of one day making all
biomedical devices capable of safely and successfully working with
MRI. For more information, please visit www.biophan.com.

Isonics Corporation (NASDAQ: ISON) is divided into two segments:
(1) Isonics Semiconductor and (2) Isonics Life Sciences. Isonics is a
world leader in isotopically engineered materials and through its
semiconductor division produces isotopically pure silicon-28 chemicals
and wafers for the semiconductor industry. For more information:
www.isonics.com.

MFIC Corporation (OTC BB: MFIC), through its Microfluidics
Division, provides patented and proprietary, high performance
Microfluidizer(R) materials processing equipment to the
pharmaceutical, biotechnology, chemical, cosmetic/personal care, and
food processing industries. To find out more about MFIC, visit its
website at www.mfics.com.

Molecular Imaging Corporation (OTC BB: MLRI) is a leading national
service provider of Positron Emission Tomography ("PET") diagnostic
imaging services. The Company operates both mobile and permanent
(fixed) PET imaging technologies for hospitals, diagnostic imaging
centers and physician group practices offices across the U.S.
www.molecularimagingcorp.com.

About Trilogy Capital Partners

Trilogy Capital Partners is a Los Angeles-based financial services
company engaged in merchant banking, strategic planning, financial
marketing and communications. Based on the simple concept that many
well-run public companies are not realizing their full value in the
marketplace, Trilogy has aggregated highly experienced executives into
a formidable financial and marketing team, which help investors
identify and maximize prospective high-return opportunities. Trilogy
is committed to identifying companies with strong management, a
compelling business model and, most importantly, companies that may be
seriously undervalued. For more information on Trilogy, or its
portfolio clients, please visit www.trilogy-capital.com.
-=-=-
C O P Y R I G H T * R E M I N D E R

This article is Copyright 2004 by Business Wire.
All articles in the clari.* news hierarchy are Copyrighted and licensed
to ClariNet Communications Corp. for distribution. Except for articles
in the biz.clarinet newsgroups, only paid subscribers may access
these articles. Any unauthorized access, reproduction or transmission
is strictly prohibited.
We offer a reward to the person who first provides us with
information that helps stop those who distribute or receive our news
feeds without authorization. Please send reports to rew...@clari.net.
[Use in...@clari.net for sales or other inquiries.]

Details on the use of ClariNet material and other info can be found in
the user documentation section of <<our web page>> <http://www.clari.net>.